James Warren

James Warren has extensive experience in pharmaceutical development and manufacturing, currently serving as SVP of Global CMC Development at Ultragenyx since May 2018, where leadership has been demonstrated in building high-performing teams and managing a substantial budget. Warren has held significant roles in various organizations, including Vice President of Manufacturing at Homology Medicines, Sr. Director at bluebird bio, and Director of Bioprocess Development at Shire, focusing on gene therapy and bioprocess development. Prior experience includes a long tenure at Merck, leading teams in vaccine manufacturing and technology transfer. Warren's military service as a Reserve IW Officer for the U.S. Navy underscores strong leadership and operational capabilities. Academic qualifications include a PhD in Cell & Molecular Biology from Lehigh University and a diploma from the U.S. Naval War College.